| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.209 | 8.975 | 12.510 | 15.878 | 19.053 | 15.045 | 13.662 | 20.715 | 15.805 | 27.445 |
| Total Income - EUR | 9.209 | 8.975 | 12.510 | 15.878 | 19.053 | 15.045 | 13.662 | 20.715 | 15.805 | 27.445 |
| Total Expenses - EUR | 7.580 | 7.641 | 9.039 | 10.606 | 11.863 | 11.779 | 11.404 | 14.326 | 14.224 | 19.567 |
| Gross Profit/Loss - EUR | 1.629 | 1.335 | 3.471 | 5.271 | 7.191 | 3.266 | 2.258 | 6.389 | 1.581 | 7.877 |
| Net Profit/Loss - EUR | 1.353 | 1.155 | 3.346 | 5.112 | 7.000 | 3.162 | 2.176 | 6.182 | 1.423 | 7.633 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medoptik S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.566 | 12.438 | 12.228 | 12.003 | 20.414 | 18.933 | 17.443 | 16.424 | 15.305 | 14.155 |
| Current Assets | 9.122 | 10.911 | 9.190 | 8.455 | 6.810 | 3.394 | 5.365 | 12.468 | 15.721 | 24.671 |
| Inventories | 8.960 | 9.785 | 8.419 | 6.790 | 3.924 | 2.283 | 2.990 | 2.348 | 4.737 | 6.706 |
| Receivables | 155 | 462 | 0 | 324 | 0 | 0 | 0 | 0 | 4.043 | 4.021 |
| Cash | 7 | 664 | 772 | 1.341 | 2.886 | 1.111 | 2.376 | 10.121 | 6.940 | 13.944 |
| Shareholders Funds | 1.247 | 2.390 | 5.695 | 10.703 | 17.496 | 20.326 | 22.051 | 28.301 | 29.638 | 37.106 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.441 | 20.960 | 15.723 | 9.756 | 9.728 | 2.001 | 757 | 591 | 1.387 | 1.720 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medoptik S.r.l.